Beijing Centergate Technologies News

Beijing Centergate Technologies: Announcement of Resolutions of the Fifth Interim Meeting of the Eighth Board of Directors in 2024

May 23 12:00 ET

Beijing Centergate Technologies: Notice on convening the 3rd Extraordinary General Meeting of Shareholders in 2024

May 23 12:00 ET

Beijing Centergate Technologies: Special instructions on redeeming executive performance pay in 2023

May 23 12:00 ET

Beijing Centergate Technologies: May 23, 2024 Investor Relations Activity Record

May 23 04:50 ET

Beijing Centergate Technologies: Legal Opinion of Beijing Hairun Tianrui Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Zhongguancun Technology Development (Holdings) Co., Ltd.

May 10 12:00 ET

Beijing Centergate Technologies: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 10 12:00 ET

Beijing Centergate Technologies: May 7, 2024 Investor Relations Activity Schedule

May 7 04:28 ET

Beijing Centergate Technologies: Notice on the receipt of the “Notice of Acceptance” of the subsidiary company Duoduo Pharmaceutical Ambroxol Hydrochloride Injection from the State Drug Administration

Apr 29 12:00 ET

Beijing Centergate Technologies: 2024 First Quarter Report

Apr 26 12:00 ET

Zhongguancun: Notice on Convening the 2023 Annual General Meeting of Shareholders (updated)

Apr 22 12:00 ET

Zhongguancun: Announcement on the approval for marketing of the subsidiary Beijing Huasubanbazole API

Apr 22 12:00 ET

Zhongguancun: Special Explanation on the Use of Annual Funds Raised

Apr 18 12:00 ET

Zhongguancun: Articles of Association (April 2024)

Apr 18 12:00 ET

Zhongguancun: Audit Committee Working Rules (April 2024)

Apr 18 12:00 ET

Zhongguancun: 2023 Independent Director Debriefing Report (Historical Record)

Apr 18 12:00 ET

Zhongguancun: Opinions of Societe Generale Securities Co., Ltd. on the storage and use of funds raised by Beijing Zhongguancun Technology Development (Holdings) Co., Ltd. in 2023 and the completion of the use of the funds raised and the cancellation of all special fund-raising accounts

Apr 18 12:00 ET

Zhongguancun: 2023 Annual Report Summary

Apr 18 12:00 ET

Zhongguancun: Nomination Committee Working Rules (April 2024)

Apr 18 12:00 ET

Zhongguancun: Announcement on Duoduo Pharmaceutical's projected major daily related transactions in 2024

Apr 18 12:00 ET

Zhongguancun: Announcement on the 2023 Profit Distribution Plan

Apr 18 12:00 ET